NR (Nicotinamide Riboside)

NR (Nicotinamide Riboside) is a 6.0–6.5/10 fit for people who want a measured NAD+ experiment, especially older adults or those tracking vascular, metabolic, or neurologic markers, because NR reliably raises NAD+ biomarkers, but functional benefits are inconsistent. Conze 2019 gives the strongest anchor, while Dollerup 2018 adds useful context without closing the case. The honest gap is simple: higher NAD+ does not automatically mean better energy, metabolism, cognition, or lifespan. That puts NR (Nicotinamide Riboside) in the tracked-experiment category, not the automatic-staple category. In practice, NR (Nicotinamide Riboside) makes the most sense when you monitor NAD+ metabolites, blood pressure, glucose markers, training capacity, fatigue, or neurologic symptoms and avoid treating NR (Nicotinamide Riboside) like a guaranteed longevity supplement.

✅ Best for: Adults 50+ seeking a regulated NAD+ precursor after covering exercise, sleep, protein, and metabolic basics. People who value Niagen chain-of-custody, GRAS/NDI history, and oral convenience over low cost. Parkinson's disease and peripheral artery disease patients who want to discuss adjunctive NR with clinicians, especially after NADPARK, NR-SAFE, and NICE PAD. Users building a broader mitochondrial stack with creatine, CoQ10, magnesium, glycine, urolithin A, and lifestyle levers. Researchers and careful self-quantifiers who care more about NAD+ biomarkers than immediate subjective effects.

❌ Avoid if: You are price-sensitive, expecting caffeine-like energy, or looking for a proven healthy-adult longevity pill. Skip NR until free NAD+ levers are covered: resistance training, zone 2 cardio, sleep regularity, protein adequacy, and meal timing. Avoid unsupervised high-dose use if pregnant, lactating, actively managing cancer, dealing with severe kidney disease, or changing Parkinson's treatment. Athletes should use only batch-tested products because WADA did not surface NR as prohibited, but supplement contamination remains product-specific. Do not use NR as replacement care for diabetes, PAD, COPD, CKD, long-COVID, cognitive impairment, or Parkinson's disease.